Table 3 Latent tuberculosis treatment completion rates stratified on reason for consultation at the TB clinic, gender and TB treatment selected for all individuals (n = 2207)
Attended LTBI Consult (n = 2207) | Started Treatment (n = 1203) | Completed Treatment (n = 795) | % completed that started treatment | |
|---|---|---|---|---|
Gender | ||||
Male | 951 | 576 | 395 | 68.6% |
Female | 1256 | 627 | 400 | 63.8% |
Reason for referral | ||||
Employment and Health Science School Screen | 735 | 351 | 224 | 63.8% |
Rule out active TB | 576 | 266 | 176 | 66.1% |
Contact | 441 | 277 | 178 | 64.3% |
Immunosuppressive therapy | 310 | 227 | 156 | 68.7% |
Immigration Surveillance | 145 | 82 | 61 | 74.4% |
LTBI Treatment | ||||
Isoniazid | - | 685 | 407 | 59.4% |
Rifampin | - | 511 | 384 | 75.1% |
Moxifloxacin | - | 5 | 3 | 60.0% |
Isoniazid and rifampin | - | 1 | 1 | 100% |
Unknown | - | 1 | 0 | 0% |